HopeStage
Back to all studies
RecruitingNCT07182890

Clostridium butyricum for anxiety and depression with indigestion

About this titleRead the official source — NCT07182890
Medication studyAges 18–80China
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 80 years.

What will I do during this study?

Participants receive a four-week probiotic or matching placebo (an inactive comparison treatment) alongside usual medication. Usual medication differs by symptom group: mosapride for post-meal distress or esomeprazole for epigastric pain. The study compares symptoms and anxiety/depression measures across these groups.

Listed locations
Xi’anSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 26, 2026
Recruitment status
Recruiting
Enrollment listed in the registry
180
Sponsor
Xijing Hospital of Digestive Diseases
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
China
Age range
From 18 Years to 80 Years
Official registry ID
NCT07182890
Official title
Show the full official title

Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia:A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial

Recruitment & locations

Currently recruiting

Xi’an

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Xijing Hospital of Digestive Diseases, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including Clostridium butyricum and placebo.

Who can participate?

Listed age limits: 18 years to 80 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies